Listed

Evolent Health, Inc.: Form 10-K for the period ended Dec 31, 2022

Filed with the SEC on Feb 24, 2023 and accepted by EDGAR at Feb 24, 2023, 17:09 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2022-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2022-10-01 to 2022-12-31$382.4mus-gaap:Revenues
Revenue12 months2022-01-01 to 2022-12-31$1.35bnus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Selling, general and administrative12 months2022-01-01 to 2022-12-31$269.3mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income12 months2022-01-01 to 2022-12-31$3.6mus-gaap:OperatingIncomeLoss
Interest expense12 months2022-01-01 to 2022-12-31$15.6mus-gaap:InterestExpense
Income tax12 months2022-01-01 to 2022-12-31−$43.4mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2022-10-01 to 2022-12-31−$11.3mus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
Net income12 months2022-01-01 to 2022-12-31−$19.2mus-gaap:NetIncomeLoss
Diluted EPS12 months2022-01-01 to 2022-12-31−$0.20us-gaap:EarningsPerShareDiluted
Basic EPS12 months2022-01-01 to 2022-12-31−$0.20us-gaap:EarningsPerShareBasic
Diluted shares (weighted)12 months2022-01-01 to 2022-12-3193,699,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow12 months2022-01-01 to 2022-12-31−$11.6mus-gaap:NetCashProvidedByUsedInOperatingActivities
Cash and equivalentsAt period end2022-12-31$188.2mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2022-12-31$478.1mus-gaap:AssetsCurrent
Total assetsAt period end2022-12-31$1.82bnus-gaap:Assets
Current liabilitiesAt period end2022-12-31$433.4mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2022-12-31$957.9mus-gaap:Liabilities
Long-term debtAt period end2022-12-31$413.0mus-gaap:LongTermDebtNoncurrent
Shareholders' equityAt period end2022-12-31$859.4mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001628908-23-000029. Last ingested by Listed: Nov 15, 2026, 04:22 ET. Listed shows no prices and gives no investment advice.